Social Networking in our industry*. PharmaExec looks at the use of social networking platforms among physicians. And, an abstract of Manhattan Research's findings (scroll past TOC to read excerpt). A …
Today’s Top Three in Pharma 012109
Will the Feds soon decide on drugs based on cost/effectiveness calculations? “They claim that they don’t want this to morph into a British-style agency that restricts access to medical products based …
Today’s Top Three in Pharma 012009
Will pharma sales forces drop (overall) by another 20% in the coming years? ZS Associates thinks yes. Interesting perspectives in this article. FDA missing yet another drug review deadline (Takeda's …
Today’s Top Three in Pharma 011909
Do gifts from pharmaceutical companies influence how physicians prescribe? This blog post gives a quick overview of the general angst over this much-flogged question. Let's forget about the …
Today’s Top Three in Pharma 011609
Will Pfizer cut its sales force again, by nearly one third? Bloomberg reports that Pfizer may eliminate nearly one-third of its sales force. The plan, which is apparently under consideration by senior …
Today’s Top Three in Pharma 011509
Wasn't able to get to a "Top Three" yesterday, as I was attending a (VERY interesting) real-time communications conference in NYC. Blog post coming on that. Meanwhile... Pfizer, Pfizer, Pfizer. 800 …